Jazz Pharma (JAZZ) Tops Q3 EPS by 7c, Guides Above the Street
Jazz Pharma (Nasdaq: JAZZ) reports Q3 EPS of $0.41, 7 cents better ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
